Pulse Oximeter Bias Linked to Serious Care Delays for Black Patients

Widespread racial bias in pulse oximetry technology is directly contributing to delayed treatments and inferior medical care for Black patients, according to new research highlighting a long-standing flaw in modern diagnostic tools. Pulse oximeters—clip-on devices used routinely in clinics and hospitals to measure blood oxygen levels—have been shown to consistently overestimate oxygen saturation in individuals with darker skin tones, concealing dangerously low oxygen levels known as occult hypoxemia.

Because clinical guidelines rely heavily on pulse oximeter readings to trigger critical interventions, this technical inaccuracy often leaves Black patients without timely access to oxygen therapy, specialized hospital admissions, or advanced treatments. The findings underscore how structural oversights in medical technology design perpetuate health disparities in minority populations.

Technical Inaccuracies and Delayed Interventions

Pulse oximeters function by beaming light through the skin to measure how much light is absorbed by oxygen-rich blood. However, pigment in darker skin can absorb light differently, leading the device to output falsely reassuring oxygen readings. For a Black patient experiencing severe respiratory distress, a faulty reading can mean the difference between receiving immediate supplemental oxygen or being sent home with an undiagnosed condition.

The consequences of this inaccuracy became particularly glaring during the COVID-19 pandemic, when real-time oxygen monitoring dictated critical hospital admission and treatment protocols. Research shows that because Black patients were more likely to experience hidden hypoxemia, their care was frequently delayed compared to white patients presenting with identical underlying oxygen deficits.

Addressing Bias in Clinical Equipment

The persistent inaccuracy of pulse oximeters points to a broader systemic issue within medical device development: historical clinical trials and product testing have overwhelmingly relied on lighter-skinned participants. Removing bias from medical hardware requires rigorous re-evaluation of how life-saving technologies are engineered, tested, and regulated before being deployed across diverse patient populations.

Regulatory bodies and research institutions are facing growing pressure to establish strict standards that mandate diverse testing cohorts. Until equitable hardware standards are universally enforced, clinicians are advised to consider skin-tone bias when evaluating pulse oximetry data and to rely on additional diagnostic checks, such as arterial blood gas tests, when treating patients with darker skin.

The Role of Diverse Medical Workforces

Mitigating racial bias in healthcare requires more than updated technology; it demands a culturally competent health workforce capable of recognizing hardware limitations and advocating for patients. Historically Black Colleges and Universities (HBCUs) play a vital role in addressing these disparities by training a significant proportion of the nation's Black physicians, nurses, and biomedical researchers.

Healthcare professionals trained at HBCUs are uniquely positioned to lead the push for health equity, both by identifying biased clinical algorithms in practice and by designing inclusive clinical trials. Increasing Black representation across medicine, engineering, and health policy ensures that equitable care remains a central priority in medical innovation.